🇺🇸 FDA
Patent

US 10039725

Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

granted A61KA61K31/09A61P

Quick answer

US patent 10039725 (Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene) held by The Regents of the University of California expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/09, A61P, A61P1/04, A61P1/16